Phase II multicenter open-label study of karenitecin in previously treated epithelial ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.
第一作者:
Kavanagh JJ
作者:
关键词
AdultAgedCamptothecinDisease-Free SurvivalDose-Response RelationshipDrugDrug Administration ScheduleFemaleFollow-Up StudiesHumansInfusionsIntravenousMaximum Tolerated DoseMiddle AgedNeoplasm InvasivenessNeoplasm RecurrenceLocalNeoplasm StagingNeoplasmsGlandular and EpithelialOvarian NeoplasmsPeritoneal NeoplasmsProbabilitySingle-Blind MethodSurvival AnalysisTreatment Outcome*成年人老年人喜树碱无病生存剂量效应关系药物用药计划表随访研究输注静脉内肿瘤侵润肿瘤复发局部肿瘤分期肿瘤腺和上皮卵巢肿瘤腹膜肿瘤概率单盲法存活率分析治疗结果
发布时间
2013-11-20
- 浏览1
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



